Last reviewed · How we verify
NCT05512689
Optimization of Ventilation Strategies in Preterm and Term Infants in a Single-center Intervention Study
NA trial testing Ventilations while using a respiratory function monitor in Lung-protective Ventilation in 90 participants. Completed in 1 March 2023.
1 March 2023
Quick facts
| Lead sponsor | Medical University of Vienna |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | sequential |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 90 |
| Start date | 1 January 2022 |
| Primary completion | 1 March 2023 |
| Estimated completion | 1 March 2023 |
| Sites | 1 location across Austria |
Drugs / interventions tested
- Ventilations while using a respiratory function monitor
Conditions studied
- Lung-protective Ventilation — all drugs for Lung-protective Ventilation →
- Respiratory Function Monitor — all drugs for Respiratory Function Monitor →
Sponsor
Medical University of Vienna
Who can join
Under 12 Months, any sex, with Lung-protective Ventilation or Respiratory Function Monitor. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study was a non-blinded, non-randomized intervention study in a single-center clinical setting, analyzing ventilation quality with and without RFM visibility.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Confirmation of successful supraglottic airway device placement in neonates using a respiratory function monitor.
Dvorsky R, Werther T, Bibl K, Schneider M, et al · · 2025 · cited 1× · PMID 39910353 · DOI 10.1038/s41390-025-03810-x
Verify or expand the search:
- PubMed search for NCT05512689
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Lung-protective Ventilation
Currently open trials in the same condition.
- NCT07123961 — Pediatric Acute Respiratory Distress Syndrome (ARDS) Management Trial · Phase 2 · recruiting
Other Medical University of Vienna trials
Trials by the same sponsor.
- NCT07473401 — Retinal Oxygen Metabolism in Children With Myopia · not yet recruiting
- NCT07511400 — The Role of NaV1.8 in Human Pain Models · EARLY_PHASE1 · not yet recruiting
- NCT07516990 — Intramuscular Injection of Mashed Parathyroid Tissue Into a Forearm During Thyroid Surgery to Prevent Permanent Postoper · NA · recruiting
- NCT07496437 — Is Cross-linked Hyaluronic Acid a Biologic Alternative for Alveolar Ridge Preservation? · NA · not yet recruiting
- NCT07290712 — Post-Intensive Care Syndrome - Multicentre Prospective Registry Database of the DACH Region · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05512689 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medical University of Vienna
- Last refreshed: 22 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05512689.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing